Novaflux Technologies

Novaflux Technologies is a medical technology company specializing in advanced extracorporeal blood treatment therapies. The company's core innovation is a proprietary vortex-enhanced filtration technology designed to improve the efficiency of dialysis and other blood purification processes. Their systems aim to enhance the removal of middle-to-large molecular weight toxins, which are often poorly addressed by conventional dialysis. Novaflux's product portfolio targets critical care and chronic conditions, including end-stage renal disease and sepsis. By optimizing fluid dynamics within the filter, the company seeks to improve patient outcomes and reduce the treatment burden associated with kidney failure.